Musely Raises $360M in Non-Dilutive Funding from General Catalyst
Musely obtains $360 million from General Catalyst through non-dilutive funding to boost customer growth while maintaining equity control. The investment targets expansion in their skin, hair, and menopause care product lines.
From TikTok’s AI to Revolutionary Drug Discovery: How ByteDance is Targeting 'Undruggable' Diseases
ByteDance’s Anew Labs, creators of TikTok's recommendation AI, is now leveraging this technology to revolutionize drug discovery, focusing on diseases once deemed untreatable. Their AI predicts molecular behavior in the human body, marking a significant breakthrough in pharmaceutical innovation.
CMS Data Breach Reveals Doctors' Social Security Numbers
The Centers for Medicare and Medicaid Services (CMS) experienced a data exposure in its provider directory system. This directory aims to improve insurer network accuracy, but the incident resulted in the unintended disclosure of doctors' Social Security numbers, raising privacy and security concerns.
Harvard Study Finds AI Surpasses Doctors in Emergency Room Diagnoses
Harvard research reveals that AI, specifically large language models, can outperform human doctors in emergency room diagnosis accuracy, showcasing AI's potential to enhance healthcare delivery.
US Healthcare Marketplaces Shared Sensitive Citizenship and Race Data with Advertising Firms
Virginia and Washington, D.C. halted the sharing of citizens' citizenship and race data from their health insurance marketplaces with advertising companies after a Bloomberg investigation uncovered the data sharing practices.
The Risk of Removing Human Touch in Digital Healthcare
While AI-driven digital health promises cost reduction and wider access by replacing clinicians, this approach risks undermining patient outcomes. The belief that human involvement in healthcare is dispensable has driven massive venture capital investments, yet the true value of human care remains critical to effective healthcare delivery.
Navigating FDA Approvals and Fundraising: Insights from BioticsAI's CEO
BioticsAI's CEO Robhy Bustami discusses the complexities of navigating FDA approvals and fundraising in healthcare. He reveals how the team remains driven despite regulatory challenges, offering a candid look at building a startup in a highly controlled environment.
OpenAI Model Excels at Diagnostic Tasks, Raising New Questions for Researchers
Researchers have demonstrated that an OpenAI artificial intelligence model can effectively handle diagnostic and clinical reasoning tasks, according to a new study published in Science. This achievement highlights AI's growing role in healthcare but also sparks discussions about the future challenges and ethical considerations of its use.
AstraZeneca to Expand UK R&D Following US-UK Trade Agreement
Following recent trade agreements between the US and the UK, AstraZeneca plans to increase its R&D activities in the UK, supported by measures that encourage higher drug expenditure. This expansion highlights the role of trade policies in fostering pharmaceutical growth and innovation.
The Evolution of AR and VR from Futuristic Concepts to Essential Business Tools
AR and VR technologies have progressed from being seen as just futuristic ideas to becoming essential tools in various industries including training, healthcare, manufacturing, and entertainment, driving real business value.
Increase in Cyberattacks Targeting Medical Devices Linked to Aging Technology
Cyberattacks on medical devices are increasing, primarily due to the continued use of legacy technology in healthcare facilities, which exposes vulnerabilities and attracts cyber threats, according to RunSafe.
New Findings Highlight Progress in U.S. Health Equity, Experts Caution About Sustainability
Recent data reveals measurable improvements in reducing health disparities across U.S. states between 2022 and 2024. However, experts warn that these positive trends could be temporary if ongoing commitment to health equity is not ensured.
AI Detects Early Pancreatic Cancer Signs Often Overlooked by Doctors
A Mayo Clinic AI model identifies early signs of pancreatic cancer in routine scans over a year before conventional diagnosis, offering hope for earlier intervention and improved patient outcomes.
FDA Commissioner Highlights Real-Time Clinical Trials as a Game-Changer in Drug Development
The FDA is introducing real-time monitoring of clinical trial data through the cloud, enabling regulators to track trial outcomes as they happen. This innovation is set to accelerate and improve the drug development process significantly.
Groundbreaking CRISPR Gene Therapy Clears Key Clinical Trial
A biotech company has achieved a significant milestone with their CRISPR-based gene editing treatment successfully passing clinical trials. They are now moving forward to obtain regulatory approval, representing a notable step forward in gene therapy development.
Stanford Professor Aims for $1 Billion Valuation with AI-Driven Human Biology Startup
Stanford professor James Zou, recognized for his FDA-approved cardiac AI, is developing Human Intelligence, a new startup leveraging AI to revolutionize human biology research. The company is pursuing $100 million funding with a targeted valuation of $1 billion, highlighting its innovative potential in biotech and AI.
AI Steps Up as Primary Care Doctors Become Scarce in America
With a growing shortage of primary care doctors in the U.S., companies like OpenAI, Amazon, and Google are leveraging AI technologies to support healthcare providers and improve patient care.
Specialized AI Enhances Precision in Workers' Compensation Decisions
Claim Clarity emphasizes the unique challenges in the workers’ compensation sector within healthcare, noting its distinct regulatory framework. Founder Jamie LaPaglia points out that specialized AI technologies are crucial for enhancing decision precision in this expanding field, helping to address complexities often overlooked when workers' comp is treated like general healthcare.
Eli Lilly Expands Oncology and Genetic Medicine Portfolio with $3.25 Billion Acquisition of Kelonia Therapeutics
Eli Lilly announced the acquisition of Kelonia Therapeutics for $3.25 billion upfront to broaden its oncology and genetic medicine capabilities, signaling a strategic move beyond its current GLP-1 focused treatments.
Half a Million UK Biobank Health Records Listed for Sale on Alibaba Website
Anonymized health records of 500,000 UK Biobank participants appeared for sale on Alibaba, prompting swift action by the UK government and Chinese partners to remove the listings. No confirmed sales took place, underscoring ongoing concerns around data security and privacy.